Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Dr. Heba Abdelmegeed, National Research Centre, Egypt

Dr. Heba Abdelmegeed is a senior researcher at the Chemistry of Natural Compounds Department, National Research Centre, Cairo, Egypt. She earned her Ph.D. in Immunology (Magna Cum Laude) from Technische Universität Dresden, Germany, and a Master’s in Pharmaceutical Sciences from Hokkaido University, Japan. With expertise in immunology, molecular biology, and cancer biology, she has authored impactful research on cancer therapeutics and immunomodulation. Her diverse academic journey spans Germany, Japan, and Egypt, with multiple publications, awards, and international conference contributions. Driven by scientific curiosity, she continues to explore cutting-edge innovations in cancer biology and immunological research.

Publication Profile

Google Scholar

Education

Dr. Heba Abdelmegeed is a distinguished immunologist with a rich academic journey across three continents. She earned her Ph.D. in Immunology (magna cum laude) from the Technische Universität Dresden, Germany , where her research focused on the activation-dependent rearrangement of macrophage lipid metabolism. Prior to that, she completed her M.Sc. in Pharmaceutical Sciences at Hokkaido University, Japan , exploring innovative approaches to activate iNKT cells using α-GalCer liposomes and interleukin 12. Her academic path began in Egypt , graduating with honors from Ain Shams University with a Bachelor’s in Pharmaceutical Sciences.

Experience

Dr. Heba Abdelmegeed is a dedicated researcher with a diverse and global professional background in pharmaceutical sciences. Since August 2020, she has served as a Senior Researcher at the Chemistry of Natural Compounds Department, NRC, Egypt . Previously, she was a Ph.D. candidate at the Technical University of Dresden, Germany , from 2015 to 2020. She also held the role of Assistant Researcher at NRC and was a Master’s candidate at Hokkaido University, Japan . Her career began as a Quality Control Analyst at NODCAR, reflecting her strong foundation in drug analysis and research.

Research Focus

Dr. Heba Abdelmegeed’s research primarily focuses on pharmacology, medicinal chemistry, and cancer biology . Her work includes developing novel anti-cancer compounds, such as quinoline and pyridine derivatives, targeting tubulin polymerization and cyclin-dependent kinases to inhibit tumor growth . She also explores nanoparticle drug delivery systems for enhanced antimicrobial and wound healing effects . Additionally, Dr. Abdelmegeed investigates inflammation, mitochondrial function, and lipid metabolism in cancer and endocrine disorders . Her multidisciplinary approach bridges molecular biology, synthetic chemistry, and computational studies to advance therapeutic strategies against cancer and infectious diseases.